Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 234 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-02-13 | 2020-06-08 | 105994 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2020-04-22 | 2020-05-20 | 112738 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2020-06-24 | 2020-10-13 | 118781 |
| ANAFRANIL | 25MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 121017 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2020-08-12 | 2020-09-04 | 122080 |
| ANAFRANIL | 25MG | TABLET | Resolved | 2021-02-26 | 2021-03-15 | 134799 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-04-05 | 2021-05-03 | 136814 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2021-04-30 | 2021-05-31 | 138352 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2021-05-25 | 2021-07-15 | 139842 |
| APO-METOPROLOL | 25MG | TABLET | Resolved | 2021-05-28 | 2021-06-28 | 140072 |
| APO-SILDENAFIL | 25MG | TABLET | Resolved | 2021-06-04 | 2021-07-19 | 140431 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2021-08-16 | 2022-05-13 | 144195 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-08-16 | 2021-09-07 | 144209 |
| APO-QUETIAPINE | 25MG | TABLET | Actual shortage | 2021-08-27 | 2021-08-27 | 144776 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2021-10-01 | 2021-12-06 | 146514 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2022-02-25 | 2022-03-29 | 155597 |
| ANAFRANIL | 25MG | TABLET | Resolved | 2022-03-18 | 2022-04-04 | 156980 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2022-11-11 | 2022-12-23 | 174332 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2022-12-05 | 2023-03-09 | 177120 |
| APO-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-09 | 2023-04-06 | 184103 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |